MKB Anesthésie
ActiveSummary
MKB Anesthésie has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €417k and a net result of €243k. Equity is growing by ~112.2% per year across the filed fiscal years. Its solvency ranks better than 87% of 2331 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 11.9 against 5.37 in 2024; short-term debt: 8.2% and cash: 63.2% of total assets), and 8.2% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
91.8%
Return on assets
53.5%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filingsDeviation from the deadline
2025
27 d late
2024
26 d late
2023
12 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€243k▲ 65.5%
2024 · €147k
2023: €24k
2024: €147k
2023 → 2025
Working capital
€408k▲ 147%
2024 · €165k
2023: €24k
2024: €165k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€27k-€174k▲ 546%€417k▲ 140%
Operating result€34k-€189k▲ 460%€285k▲ 50.8%
Net result€24k-€147k▲ 514%€243k▲ 65.5%
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 51% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €455k
Fixed assets
€10k ▲ 11.3%
Current assets
€445k ▲ 119%
Equity and liabilities €455k
Equity
€417k ▲ 140%
Debt
€37k ▼ 1.3%
Debt's share of the balance-sheet total falls from 17.9% to 8.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€287k▲
2024 · €190k
Cash flow
€246k▲
2024 · €148k
Current ratio
11.90▲
2024 · 5.37
Debt to equity
0.09▼
2024 · 0.22
ROE
58.3%▼
2024 · 84.5%
ROA
53.5%▼
2024 · 69.4%
Interest coverage
1855.42▼
2024 · 5054.51
Debt ≤ 1 year
€37k▼
2024 · €38k
Income taxes
€42k▲
2024 · €42k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 35 lines
Balance sheet
Code20242025
Assets
Total assets20/58€212k€455k▲
Fixed assets21/28€9k€10k▲
Tangible fixed assets22/27€9k€10k▲
Furniture and vehicles24€9k€10k▲
Current assets29/58€203k€445k▲
Amounts receivable within one year40/41€21k€47k▲
Trade receivables40€1k€4k▲
Other amounts receivable41€20k€43k▲
Cash at bank and in hand54/58€95k€287k▲
Deferred charges and accrued income490/1€87k€111k▲
Equity and liabilities
Total equity and liabilities10/49€212k€455k▲
Equity10/15€174k€417k▲
Contributions10/11€3k€3k=
Reserves13€24k€24k=
Distributable reserves133€24k€24k=
Profit (loss) carried forward14€147k€390k▲
Amounts payable17/49€38k€37k▼
Amounts payable within one year42/48€38k€37k▼
Taxes, remuneration and social security45€38k€37k▼
Taxes450/3€38k€37k▼
Other amounts payable47/48-€11
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€611€3k▲
Other operating charges640/8-€50
Gross operating margin9900€190k€287k▲
Operating profit (loss)9901€189k€285k▲
Financial income75/76B€437€931▲
Recurring financial income75€437€931▲
Financial charges65/66B€38€155▲
Recurring financial charges65€38€155▲
Profit (loss) for the period before taxes9903€189k€286k▲
Income taxes67/77€42k€42k▲
Profit (loss) for the period9904€147k€243k▲
Profit (loss) for the period to be appropriated9905€147k€243k▲
Appropriation of the result
Profit (loss) to be appropriated9906€147k€390k▲
Profit (loss) brought forward from the previous period14P-€147k
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 27 days late
2025
31-12
Financial
Highest result since 2023net €243k ▲65.5%
Operating result €285k, net result €243k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 11.90
Current ratio from 5.37 to 11.90; short-term debt falls from €38k to €37k.
31-12
Financial
Equity above €200kEq €417k ▲140%
3 profitable years in a row build equity to €417k.
26-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 26 days late
2024
31-12
Financial
Equity above €150kEq €174k ▲546%
2 profitable years in a row build equity to €174k.
12-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 12 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sprimont · 1 establishment unit since 2023
Ground area
6,999 m²
Building footprint
136 m²
Volume, LiDAR
1,101 m³
Parcel 62045A0049/00H005, Wallonia · tallest building 10.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
MKB Anesthésie
since 20232.349.014.752
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62045A0049/00H005 | Wallonia | 6,999 m² | 1 · 136 m² | 10.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
254900NMXD48K9IZLP82
Similar companies · same sector, comparable size
MEDISCH KABINET Dr. DE BAETS M.
BE 0437.676.371
Maasmechelen · Eq €417,061
CABINET MEDICAL DU DOCTEUR BRICTEUX
BE 0448.343.896
Liège · Eq €417,479
Dr. Alexandra Kluyskens - MKA
BE 0781.559.484
Sint-Martens-Latem · Eq €416,784
Attentia Aviation Medical
BE 0886.963.545
Zaventem · Eq €417,781
Vetiz
BE 0885.736.197
Keerbergen · Eq €417,898
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,550 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-09-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.